Tags:BioTechCareDevelopmentDiagnosticsHealthPharmacyPlatformProductScienceTechnology
Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides. In addition to its internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.
Total raised: $7.816326M

Investors 4

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
10.09.2018-$7.816326M-Arecor sec...

Mentions in press and media 21

DateTitleDescriptionCategoryAuthorSource
16.12.2020Arecor ann...Arecor announces publication o...--cambridgen...
16.12.2020Arecor ann...Arecor announces publication o...--cambridgen...
15.06.2020ARECOR pre...ARECOR presents positive resul...--cambridgen...
19.03.2020Arecor ext...Arecor extends multi-product c...--cambridgen...
05.12.2019Arecor ann...Arecor announces positive head...--cambridgen...
05.12.2019Arecor ann...Arecor announces positive head...--cambridgen...
22.10.2019Arecor and...Arecor and JDRF sign a joint r...--cambridgen...
11.03.2019Arecor app...Arecor appoints Chief Financia...--cambridgen...
11.03.2019Arecor app...Arecor appoints Chief Financia...--cambridgen...
13.02.2019Super-fast...Super-fast-acting prandial ins...--cambridgen...
Show more